Published in Medical Letter on the CDC and FDA, December 25th, 2011
"Monitoring disease reduction requires real-time case-based disease surveillance and appropriate...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.